Financing Drugs in South-East Asia. Report of the Second Meeting of the WHO/SEARO Working Group on Drug Financing - Health Economics and Drugs No. 008
(1998; 72 pages)

Table of Contents

	Acknowledgements
	Abbreviations and acronyms
	Executive summary
	1. Introduction
		1.1 Opening session
		1.2 Objectives of the second meeting
		1.3 Message from the Regional Director (Dr Uton Muchtar Rafei, Regional Director WHO South-East Asia Region)
	2. Country presentations on drug financing
		2.1 Indonesia (presented by Dra Andayaningsih)
		2.2 Myanmar (presented by Dr Myint Thaung)
		2.3 Nepal (presented by Dr K.B. Singh Karki)
		2.4 Thailand (presented by Dr Porntep Siriwanarangsun)
	3. Field visit: Sleman district
		3.1 Descriptions of the health units (compiled by Dr Sri Suryawati)
		3.2 Results of the field visit (compiled by Dr Yos Hudyono)
		3.3 Summary
	4. Drug financing issues
		4.1 The role of the state in drug financing (presented by Dr Germán Velásquez)
		4.2 Review of cost-sharing experiences (presented by Dr Sri Suryawati)
		4.3 Experiences of the Myanmar Essential Drugs Project in drug financing and sustaining availability of essential drugs (presented by Professor U Hla Myint)
		4.4 Drug financing and health reform (presented by Dr Germán Velásquez) (Summary of Antezana F, Velásquez G. Drugs and health sector reform. Geneva: World Health Organization; 1996 (unpublished document - WHO/TFHE/96.2)).
	5. Country priorities for drug financing
		5.1 Indonesia
		5.2 Myanmar
		5.3 Nepal
		5.4 Thailand
	6. Priorities for work group action
		6.1 Increase efficient use of available budget
		6.2 Reduce production and distribution costs
		6.3 Policies/mechanisms to improve existing cost-sharing schemes in the region
		6.4 Mechanisms to reduce the cost/price of drugs
	7. Conclusions and recommendations
		7.1 Country priorities for action
		7.2 Recommendations
	Annex A: Agenda
	Annex B: List of participants
		Indonesia
		Myanmar
		Nepal
		Thailand
		WHO Secretariat
	Annex C: References
	Annex D: Evaluation of the meeting/priorities for the working group

Financing Drugs in South-East Asia. Report of the Second Meeting of the WHO/SEARO Working Group on Drug Financing - Health Economics and Drugs No. 008

WHO/DAP/98.15
SEA/Drugs/140

Health Economics and Drugs

DAP Series No. 8

Report of the second meeting of the
WHO/SEARO Working Group on Drug Financing

Yogyakarta, Indonesia
24-28 November 1997

World Health Organization
Action Programme on Essential Drugs, Geneva
Regional Office for South-East Asia, New Delhi

Prepared by:

Budiono Santoso, Kin Shein, Sri Suryawati
Karin Timmermans, Germán Velásquez
Action Programme on Essential Drugs, Geneva
Regional Office for South-East Asia, New Delhi